C5a contributes to intraocular inflammation by affecting retinal pigment epithelial cells and immune cells

British Journal of Ophthalmology

Volumn 95, Issue 12, 2011, Pages 1738-1744

  Hu, Mengjun ^a   Liu, Baoying ^a   Jawad, Shayma ^a   Ling, Diamond ^a   Casady, Megan ^a   Wei, Lai ^a   Nussenblatt, Robert B ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA2;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL INTERACTION; CELL SURFACE; CELL VIABILITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; EYE INFLAMMATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MITOCHONDRION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; COMPLEMENT C5A; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE; EYE DISEASES; GENE EXPRESSION; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; PIGMENT EPITHELIUM OF EYE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANAPHYLATOXIN C5A; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 81555204467     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300235     Document Type: Article

References (33)

1. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 2007;44:3901-8.
2. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349:614-17.
3. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 2006;103:2328-33.
4. Copland DA, Hussain K, Baalasubramanian S, et al. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol 2010;159:303-14.
5. Boulay F, Mery L, Tardif M, et al. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 1991;30:2993-9.
6. Fukuoka Y, Medof EM. C5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19. Curr Eye Res 2001;23:320-5.
7. Fukuoka Y, Strainic M, Medof ME. Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a. Clin Exp Immunol 2003;131:248-53.
8. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003;3:879-89.
9. Zamiri P, Masli S, Streilein JW, et al. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest Ophthalmol Vis Sci 2006;47:3912-18.
10. Liversidge J, McKay D, Mullen G, et al. Retinal pigment epithelial cells modulate lymphocyte function at the blooderetina barrier by autocrine PG-2 and membrane-bound mechanisms. Cell Immunol 1993;149:315-30.
11. Caspi RR, Roberge FG, Nussenblatt RB. Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science 1987;237:1029-32.
12. Jorgensen A, Wiencke AK, la Cour M, et al. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci 1998;39:1590-9.
13. Percopo CM, Hooks JJ, Shinohara T, et al. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol 1990;145:4101-7.
14. Benelli R, Lorusso G, Albini A, et al. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 2006;12:3101-15.
15. Ikeda Y, Yonemitsu Y, Onimaru M, et al. The regulation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium. Exp Eye Res 2006;83:1031-40.
16. Kim BJ, Li Z, Fariss RN, et al. Constitutive and cytokine-induced GITR ligand expression on human retinal pigment epithelium and photoreceptors. Invest Ophthalmol Vis Sci 2004;45:3170-6.
17. Mahesh SP, Li Z, Liu B, et al. Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines. Eur J Immunol 2006;36:2128-38.
18. Liu B, Li Z, Mahesh SP, et al. HTLV-1 infection of human retinal pigment epithelial cells and inhibition of viral infection by an antibody to ICAM-1. Invest Ophthalmol Vis Sci 2006;47:1510-15.
19. Shi G, Maminishkis A, Banzon T, et al. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2008;49:4620-30.
20. Nussenblatt RB, Ferris F 3rd. Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 2007;144:618-26.
21. Nussenblatt RB, Liu B, Li Z. Age-related macular degeneration: an immunologically driven disease. Curr Opin Investig Drugs 2009;10:434-42.
22. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4.
23. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005;102:7227-32.
24. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
25. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
26. Prosser BE, Johnson S, Roversi P, et al. Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 2007;204:2277-83.
27. Scholl HP, Charbel Issa P, Walier M, et al. Systemic complement activation in age-related macular degeneration. PLoS One 2008;3:e2593.
28. Anderson DH, Mullins RF, Hageman GS, et al. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002;134:411-31.
29. Hageman GS, Mullins RF. Molecular composition of drusen as related to substructural phenotype. Mol Vis 1999;5:28.
30. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 2002;99:14682-7.
31. Sohn JH, Bora PS, Jha P, et al. Complement, innate immunity and ocular disease. Chem Immunol Allergy 2007;92:105-14.
32. Strainic MG, Liu J, Huang D, et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008;28:425-35.
33. Hubschman JP, Reddy S, Schwartz SD. Age-related macular degeneration: current treatments. Clin Ophthalmol 2009;3:155-66.